Diazepam (diazepam oral) NDC 62135-767

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-767Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0767Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-767-24	62135076724	2 TRAY in 1 BOX (62135-767-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (62135-767-45)Marketed from Jul 12, 2024
62135-767-47	62135076747	473 mL in 1 BOTTLE (62135-767-47)Marketed from Aug 17, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Diazepam
Generic name (nonproprietary): diazepam oral
Active ingredients: Diazepam — 5 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206477
Marketing start: Jun 24, 2016
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)
Identifiers: Product ID 62135-767_4517b811-0a91-89f5-e063-6294a90a9a30SPL ID 4517b811-0a91-89f5-e063-6294a90a9a30SPL set ID cdb839fb-27e5-4a11-aed6-da0a7ab6e996RxCUI 309843, 309844UNII Q3JTX2Q7TUUPC 0362135767242, 0362135768430, 0362135767471
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135076724 followed by a unit qualifier and the quantity

Package 62135-0767-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 3, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS Diazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis. Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia), athetosis, and stif…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206477

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206477
Product	Strength	Form · route	Labeler	Product NDC
Diazepamdiazepam oral	Diazepam 5 mg/5mL	SolutionOral	Chartwell Governmental & Specialty RX, LLC.	68999-767